Arm's stock has also shown extreme sensitivity to any signal that it may be excluded from a competitor's major chip initiative, such as an 8% drop on April 27 over such concerns .

The AGI CPU: Arm's High-Stakes Bet

Arm's bull case rests entirely on the commercial traction of its new AGI CPU — the company's first in-house production silicon. The 136-core Neoverse V3 chip, built on TSMC's 3nm process, is designed specifically for agentic AI inference workloads in data centers . This marks a strategic pivot from pure IP licensing to selling physical chips, a first in the company's 35-year history .

Customer adoption has been strong:

• Meta and OpenAI were announced as initial customers at the March "Arm Everywhere" event .
• Oracle and ByteDance were announced at Computex in early June as adopters .
• Cloudflare and other ecosystem partners have also been named onboard .
• CEO Rene Haas stated that customer response has been "strong," and Arm doubled its demand forecast from $1 billion to over $2 billion across FY2027 and FY2028 — disclosed in the May 6 earnings letter to shareholders .
• Arm also announced a long-term revenue target of $20 billion in annual revenue by 2028, underpinned by the AGI CPU ramp .

The available sources do not explicitly confirm Cerebras or SAP as publicly announced AGI CPU customers, though multiple reports name them as committed .

Valuation: The Elephant in the Room

The tension between the AI growth story and the stock's extreme valuation is the core driver of Arm's volatility.

Valuation metrics:

• Arm's trailing P/E was around 431x as of early July, compared to a semiconductor industry average of roughly 24x .
• Its forward P/E was approximately 147x in mid-June .
• Simply Wall St estimated the stock as 137% overvalued relative to its fair value estimate .

Analyst ratings and price targets:

Most averages sit in the $240–$296 range, well below the mid-$300s where the stock was recently trading. Even analysts with Buy ratings see the stock as significantly ahead of near-term fundamentals .

Broader Risks: Smartphone Dependence and Supply Constraints

Beyond valuation, Arm faces two fundamental business risks:

• Smartphone exposure risk: Roughly 50% of Arm's royalty revenue is tied to smartphone and mobile device chips . Disappointing initial sales of Apple's iPhone 16 have previously hit the stock, and any weakness in smartphone end-market demand directly pressures Arm's core royalty stream. CEO Rene Haas has warned that phone unit growth could "turn negative" due to memory chip shortages .
• Manufacturing capacity risk: On the May 6 earnings call, management disclosed it had not secured the manufacturing capacity needed to meet demand beyond the initial $1 billion tranche of AGI CPU orders, which contributed to a 7.25% sell-off that day . Arm has secured supply for only about half of current demand, limiting near-term growth .

The Bottom Line

Arm's volatile trading reflects a fundamental tension between massive AI optimism (the AGI CPU narrative, $2 billion+ in early demand, and a long-term $20 billion revenue target) and an extreme valuation that leaves the stock exposed to any macro or sector rotation. The July 1 decline is consistent with the ongoing sector-wide AI stock pullback rather than a single new company-specific catalyst. The analyst consensus sees 30–40% downside from recent levels, and fundamental risks of smartphone-cycle dependence and manufacturing scale-up challenges persist alongside the AI upside story.

Arm's stock has also shown extreme sensitivity to any signal that it may be excluded from a competitor's major chip initiative, such as an 8% drop on April 27 over such concerns .

The AGI CPU: Arm's High-Stakes Bet

Arm's bull case rests entirely on the commercial traction of its new AGI CPU — the company's first in-house production silicon. The 136-core Neoverse V3 chip, built on TSMC's 3nm process, is designed specifically for agentic AI inference workloads in data centers . This marks a strategic pivot from pure IP licensing to selling physical chips, a first in the company's 35-year history .

Customer adoption has been strong:

• Meta and OpenAI were announced as initial customers at the March "Arm Everywhere" event .
• Oracle and ByteDance were announced at Computex in early June as adopters .
• Cloudflare and other ecosystem partners have also been named onboard .
• CEO Rene Haas stated that customer response has been "strong," and Arm doubled its demand forecast from $1 billion to over $2 billion across FY2027 and FY2028 — disclosed in the May 6 earnings letter to shareholders .
• Arm also announced a long-term revenue target of $20 billion in annual revenue by 2028, underpinned by the AGI CPU ramp .

The available sources do not explicitly confirm Cerebras or SAP as publicly announced AGI CPU customers, though multiple reports name them as committed .

Valuation: The Elephant in the Room

The tension between the AI growth story and the stock's extreme valuation is the core driver of Arm's volatility.

Valuation metrics:

• Arm's trailing P/E was around 431x as of early July, compared to a semiconductor industry average of roughly 24x .
• Its forward P/E was approximately 147x in mid-June .
• Simply Wall St estimated the stock as 137% overvalued relative to its fair value estimate .

Analyst ratings and price targets:

Most averages sit in the $240–$296 range, well below the mid-$300s where the stock was recently trading. Even analysts with Buy ratings see the stock as significantly ahead of near-term fundamentals .

Broader Risks: Smartphone Dependence and Supply Constraints

Beyond valuation, Arm faces two fundamental business risks:

• Smartphone exposure risk: Roughly 50% of Arm's royalty revenue is tied to smartphone and mobile device chips . Disappointing initial sales of Apple's iPhone 16 have previously hit the stock, and any weakness in smartphone end-market demand directly pressures Arm's core royalty stream. CEO Rene Haas has warned that phone unit growth could "turn negative" due to memory chip shortages .
• Manufacturing capacity risk: On the May 6 earnings call, management disclosed it had not secured the manufacturing capacity needed to meet demand beyond the initial $1 billion tranche of AGI CPU orders, which contributed to a 7.25% sell-off that day . Arm has secured supply for only about half of current demand, limiting near-term growth .

The Bottom Line

Arm's volatile trading reflects a fundamental tension between massive AI optimism (the AGI CPU narrative, $2 billion+ in early demand, and a long-term $20 billion revenue target) and an extreme valuation that leaves the stock exposed to any macro or sector rotation. The July 1 decline is consistent with the ongoing sector-wide AI stock pullback rather than a single new company-specific catalyst. The analyst consensus sees 30–40% downside from recent levels, and fundamental risks of smartphone-cycle dependence and manufacturing scale-up challenges persist alongside the AI upside story.